General Pharmacology Flashcards

1
Q

Michaelis-menten kinetics:

Km is ____ related to the affinity of the enzyme for its substrate

Vmax is _____ proportional to the enzyme concentration

Most enzymatic reactions follow a hyperbolic curve (i.e., Michaelis menten kinetics); however, enzymatic reactions that exhibit a ______ curve usually indicate cooperative kinetics (e.g., Hgb)

A

Inversely

Directly

Sigmoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

On a lineweaver-burk plot, the further to the right the x-intercept (i.e., the closer to zero), the _____ the Km and the _____ the affinity

A

Greater; lower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Reversible competitive inhibitors effects on Vmax and Km

A

Vmax unchanged

Km increased

[decrease the potency of the substrate, but can be overcome by increase substrate concentration]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Irreversible competitive inhibitors effects on Vmax and Km

A

Vmax decreased

Km unchanged

[decrease the efficacy of the substrate]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Noncompetitive inhibitors effects on Vmax and Km

A

Vmax decreased

Km unchanged

[decrease the efficacy of the substrate]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Fraction of administered drug reaching systemic circulation unchanged; equal to 100% for an IV dose

A

Bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Theoretical volume occupied by a total amount of the drug in the body relative to its plasma concentration

A

Volume of distribution (Vd)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Apparent Vd of plasma protein-bound drugs can be altered by liver and kidney disease (decreased protein binding, increased Vd); drugs may distribute in more than one compartment.

How is Vd calculated?

A

Vd = amount of drug in the body/plasma drug concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Large/charged molecules and plasma-protein bound drugs in the intravascular compartment are associated with a ______ Vd

A

Low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Small lipophilic molecules, especially if bound to tissue protein, found in all tissues including fat are associated with a _____ Vd

A

High

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Small hydrophilic drugs found in the ECF are associated with a ____ Vd

A

Medium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Volume of plasma cleared of drug per unit time; may be imapired with defects in cardiac, hepatic, or renal function

A

Clearance (CL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Clearance (CL) calculation (2 equations)

A

CL = Rate of elimination of drug/plasma drug concentration

[or]

CL =Vd x Ke (elimination constant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

1/2 life is the amount of time required to change the amount of drug in the body by 1/2 during elimination

in first order kinetics, a drug infused at a constant rate takes _____ half-lives to reach a steady state. It takes 3.3 half lives to reach ____ of the steady-state level

A

4-5; 90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Calculation for half life in first order elimination

A

t(1/2) = [0.7 x Vd]/CL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Percent of drug remaining after 1, 2, 3, and 4 half lives in first order kinetics

A

50% remaining after 1 half life

25% remaining after 2 half lives

  1. 5% remaining after 3 half lives
  2. 25% remaining after 4 half lives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Calculation for loading dose

A

Loading dose = [Cp x Vd]/F

Cp = target plasma concentration at steady state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Calculation for maintenance dose

A

Maintenance dose = [Cp x CL x tau]/F

Cp = target plasma concentration at steady state

Tau = dosage interval (time between doses) if not administered continuously

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

In renal or liver disease, the maintenance dose typically ______ and the loading dose is ______

Time to steady state depends primarily on _______ and is independent of dose and dosing frequency

A

Decreases; unchanged

t(1/2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Aspirin and acetaminophen are an example of a _______ drug interaction in which the effect of substance A and B together is equal to the sum of their individual parts

A

Additive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

The effect of cortisol on catecholamine responsiveness is an example of a _______ drug interaction in which presence of substance A is required for the full effects of substance B

A

Permissive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Clopidogrel with aspirin is an example of a _______ drug interaction in which effect of substance A and B together is greater than the sum of their individual effects

A

Synergistic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Nitrates, niacin, phenylephrine, LSD, and MDMA are an example of a _______ drug interaction in which there is an acute decrease in response to a drug after initial/repeated adminstration

A

Tachyphylactic (aka tolerance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is zero-order elimination?

A

Rate of elimination is constant regardless of amount of drug eliminated per unit time

Cp decreases linearly with time

Examples include Phenytoin, Ethanol, and ASA (at high or toxic concentrations)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
The rate of first-order elimination is directly proportional to _____
The drug concentration [constant fraction of drug eliminated per unit time; Cp decreases exponentially with time — applies to most drugs]
26
Phenobarbital, methotrexate, and aspirin (salicylates) are examples of _____ ____ in which overdoses can be treated with sodium bicarbonate to _______ urine
Weak acids; alkalinize
27
TCAs and amphetamines are examples of ____ ____ in which overdoses can be treated with ___ ____ to acidify urine
Weak bases; ammonium chloride [note that TCA toxicity is generally treated with sodium bicarbonate to overcome the sodium channel-blocking activity of TCAs, but not for accelerating drug elimination]
28
Phase I drug metabolism
Reduction, oxidation, hydrolysis with cytochrome P450 usually yield slightly polar, water-soluble metabolites (often still active) [geriatric pts lose phase I first R-OH]
29
Phase II drug metabolism
Conjugation (methylation, glucuronidation, acetylation, sulfation) usually yields very polar, inactive metabolites (renally excreted) [geriatric pts retain phase II, pts who are slow acetylators have increased side effects from certain drugs because of low rate of metabolism (e.g. INH)]
30
Therapeutic index (TD50/ED50) is a measure of drug safety; safer drugs have _____ TI values
Higher [TD = median toxic dose, ED50 = median effective dose]
31
G-protein class and major functions α-1 sympathetic receptors
Gq Increase vascular smooth muscle contraction Increase pupillary dilator muscle contraction (mydriasis) Increased intestinal and bladder sphincter muscle contraction
32
G-protein class and major functions α-2 sympathetic receptors
Gi Decreased sympathetic (adrenergic) outflow Decreased insulin release Decreased lipolysis Increased platelet agg Decreased aqueous humor production
33
G-protein class and major functions β1 sympathetic receptors
Gs Increased heart rate, contractility, renin release, and lipolysis
34
G-protein class and major functions β2 sympathetic receptors
Gs Vasodilation, bronchodilation Increased lipolysis, increased insulin release, increased glycogenolysis, decreased uterine tone (tocolysis), increased aqueous humor production, increased cellular K+ uptake
35
G-protein class and major functions β3 sympathetic receptors
Gs Increased lipolysis, thermogenesis in skeletal muscle, and bladder relaxation
36
G-protein class and major functions M1 parasympathetic receptors
Gq Mediates higher cognitive functions, stimulates enteric nervous system
37
G-protein class and major functions M2 parasympathetic receptors
Gi Decreased heart rate and contractility of atria
38
G-protein class and major functions M3 parasympathetic receptors
Gq Increased exocrine gland secretions (e.g., lacrimal, sweat, salivary, gastric acid), increased gut peristalsis, increased bladder contraction, bronchoconstriction, increased pupillary sphincter muscle contraction (miosis), ciliary muscle contraction (accomodation), increased insulin release, endothelium-mediated vasodilation
39
G-protein class and major functions D1 receptors
Gs Relaxes renal vascular smooth muscle Activates direct pathway of striatum
40
G-protein class and major functions D2 receptors
Gi Modulates transmitter release, esp in the brain, inhibits direct pathway of striatum
41
G-protein class and major functions H1 receptors
Gq Increased nasal and bronchial mucous production Increased vascular permeability Bronchoconstriction, pruritis, pain
42
G-protein class and major functions H2 receptors
Gs Increased gastric acid secretion
43
G-protein class and major functions V1 receptors
Gq Increased vascular smooth muscle contraction
44
G-protein class and major functions V2 receptors
Gs Increased H2O permeability and reabsorption via upregulating aquaporin-2 in collecting tubules of kidney; increased release of vWF
45
Cholinomimetic direct acting agonist that activates bladder smooth muscle; resistant to AChE. No nicotinic activity. Treatment for urinary retention
Bethanechol
46
Cholinomimetic direct acting agonist that works like ACh but is resistant to AChE; constricts pupils and relieves intraocular pressure in open-angle glaucoma
Carbachol
47
Cholinomimetic direct acting agonist that stimulates muscarinic receptors in airway when inhaled; used in challenge test for dx of asthma
Methacholine
48
Cholinomimetic direct acting agonist that contracts ciliary muscle of eye (open-angle glaucoma), pupillary sphincter (closed-angle glaucoma); resistant to AChE, can cross BBB (tertiary amine) Potent stimulator of sweat, tears, and saliva; treats open and close-angle glaucoma as well as xerostomia found in Sjogren syndrome
Pilocarpine
49
Cholinomimetic indirect acting agonist (AChE’s) that are first-line for Alzheimer disease
Donepezil Rivastigmine Galantamine
50
Cholinomimetic indirect acting agonist (AChE’s) historically used to diagnose to dx myasthenia gravis; replaced by Anti-AChR Ab test
Edrophonium
51
Cholinomimetic indirect acting agonist (AChE’s) that does not penetrate the CNS; used to tx postop and neurogenic ileus and urinary retention, myasthenia gravis, reversal of neuromuscular blockade (postop)
Neostigmine
52
Cholinomimetic indirect acting agonist (AChE’s) that freely crosses the BBB —> CNS (tertiary amine); antidote for anticholinergic toxicity (e.g., atropine overdose)
Physostigmine
53
Cholinomimetic indirect acting agonist (AChE’s) that increases muscle strength; often used with glycopyrrolate, hyoscyamine, or propantheline to control its side effects; used to tx Myasthenia gravis (long acting); does not penetrate CNS (quaternary amine)
Pyridostigmine
54
Use of cholinomimetic agents should prompt you to watch for exacerbation of what 3 conditions in susceptible patients?
COPD Asthma Peptic ulcers
55
Muscarinic effects of anticholinesterase poisoning
DUMBBELSS: ``` Diarrhea Urination Miosis Bronchospasm Bradycardia Emesis Lacrimation Sweating Salivation ```
56
Nicotinic and CNS effects of anticholinesterase poisoning
Nicotinic: neuromuscular blockade (mechanism similar to succinylcholine) CNS: respiratory depression, lethargy, seizures, coma
57
Methods for reversal of muscarinic and nicotinic effects of anticholinesterase poisoning
Muscarinic effects reversed by atropine, a competitive inhibitor (can cross BBB to relieve CNS symptoms as well) Nicotinic effect reversed by pralidoxime, regenerates AChE if given early; pralidoxime does not readily cross BBB
58
3 muscarinic antagonists that produce mydriasis and cycloplegia
Atropine Homatropine Tropicamide
59
2 muscarinic antagonists that treat Parkinson disease and acute dystonia
Benztropine | Trihexyphenidyl
60
Muscarinic antagonist that can be used parenterally in pre-op to reduce airway secretions, or orally to treat drooling and peptic ulcer
Glycopyrrolate
61
2 muscarinic antagonists used as antispasmotics for IBS
Hyoscyamine | Dicyclomine
62
2 muscarinic antagonists used to treat COPD and asthma
Ipratropium | Tiotropium
63
3 muscarinic antagonists used to reduce bladder spasms and urge urinary incontinence (overactive bladder)
Oxybutynin Solifenacin Tolterodine
64
Muscarinic antagonist used to treat motion sickness
Scopolamine
65
Effects of atropine (muscarinic antagonist) on eye, airway, stomach, gut, and bladder
Eye — pupil dilation, cycloplegia Airway — bronchodilation, decreased secretions Stomach — decreased acid secretion Gut — decreased motility Bladder — decreased urgency in cystitis
66
AEs of atropine
``` Increased body temp Increased HR Dry mouth Dry flushed sin Cycloplegia Constipation Disorientation ``` Can cause acute angle-closure glaucoma in the elderly (due to mydriasis), urinary retention in men with BPH, and hyperthermia in infants [Hot as a hare, Dry as a bone, Red as a beet, Blind as a bat, Mad as a hatter, Full as a flask]
67
3 direct sympathomimetics that act at beta2>beta1: _______ is used for acute asthma/COPD _______ is used for long-term asthma/COPD _______ is used for acute bronchospasm in asthma and tocolysis
Albuterol Salmeterol Terbutaline
68
Direct sympathomimetic that acts on beta1>beta2, alpha; applications include heart failure, cardiogenic shock (inotropic>chronotropic), and cardiac stress testing
Dobutamine
69
Direct sympathomimetic that acts on D1 = D2 > beta > alpha; applications include unstable bradycadia, HF, shock; inotropic and chronotropic effects at lower doses due to beta effects; vasoconstriction at high doses due to alpha effects
Dopamine
70
Direct sympathomimetic that acts on beta > alpha receptors; applications include anaphylaxis, asthma, open-angle glaucoma; alpha effects predominate at high doses. significantly stronger effect at beta 2 receptors than NE
Epinephrine
71
Direct sympathomimetic that acts on D1 receptors; treats postop HTN, hypertensive crisis. Acts as a vasodilatory (coronary, peripheral, renal, and splanchnic); promotes natriuresis. Can cause hypotension and tachycardia
Fenoldopam
72
Direct sympathomimetic that acts on beta 1= beta 2 receptors; applications include electrophysiologic eval of tachyarrythmias. Can worsen ischemia; has negligible alpha effect
Isoproterenol
73
Direct sympathomimetic that acts on alpha1 receptors; treats autonomic insufficiency and postural hypotension. May exacerbate supine HTN
Midodrine
74
Direct sympathomimetic that acts on beta3 receptors; treats urinary urge incontinence or overactive bladder
Mirabegron
75
Direct sympathomimetic that acts on alpha 1> alpha 2 > beta1 receptors; applications include hypotension, septic shock
NE
76
Direct sympathomimetic that acts on alpha 1 > alpha 2 receptors; treats hypotension, used in ocular procedures (mydriatic), rhinitis (decongestant), and ischemic priapism
Phenylephrine
77
Indirect sympathomimetic that acts as indirect general agonist, reuptake inhibitor, also releases stored catecholamines; treats narcolepsy, obesity, and ADHD
Amphetamine
78
Indirect sympathomimetic that acts as an indirect general agonist and reuptake inhibitor; causes vasoconstriction and local anesthesia. Caution when giving beta blockers if intoxication is suspected — can lead to unopposed alpha1 activation —> extreme HTN and coronary vasospasm
Cocaine
79
Indirect sympathomimetic that acts as indirect general agonist and releases stored catecholamines; applications include nasal decongestion, urinary incontinence, and hypotension
Ephedrine
80
2 sympatholytics (alpha-2 agonists) that are used in hypertensive urgency (limited situations), ADHD, tourette syndrome, and symptom in opioid withdrawal; AEs include CNS depression, bradycardia, hypotension, respiratory depression, miosis, rebound HTN with abrupt cessation
Clonidine | Guanfacine
81
Sympatholytic (alpha-2 agonists) that treats HTN in pregnancy; AEs include direct Coombs + hemolysis and drug-induced lupus
Alpha-methyldopa
82
Sympatholytic (alpha-2 agonists) that is used for relief of spasticity; AEs include hypotension, weakness, xerostomia
Tizanidine